期刊文献+

代谢正常肥胖的研究进展 被引量:5

Research progress of the metabolically healthy but obese
原文传递
导出
摘要 代谢正常肥胖(MHO)是近年来备受关注的一类肥胖亚群,以肥胖但高胰岛素敏感性为特征,占肥胖群体的20%~30%。由于某些保护机制存在,MHO人群与以往所说的"高危肥胖"人群,在临床表现、炎症、代谢谱、治疗及预后等方面均截然不同,深入探索其代谢保护机制及临床参数的纵向变化对肥胖研究和卫生保健工作意义重大。本文从流行病学、界定标准、保护机制、研究前景等方面全面概括MHO的研究进展,旨在推进科研及临床工作者对这一重要肥胖亚型的认识。 Metabolically Healthy but Obese(MHO)individuals are a subset of obesity concerned in recent years and characterized by obesity and high insulin sensitivity,accounting for 20%-30%of obese population.MHO individuals are distinguished from those"at-risk obese" in aspects of clinical manifestations,inflammation,metabolic profiles,treatment and prognosis.Further study of its metabolic protection mechanisms and clinical longitudinal changes is of great significance for obesity research and health care.This review provided a comprehensive overview of MHO in aspects of epidemiology,standard definition,protection mechanisms and research prospects,for promoting an advancing understanding of this important obesity subtypes.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2012年第1期75-78,共4页 Chinese Journal of Diabetes
基金 国家自然科学基金资助项目(30900708)
关键词 代谢正常肥胖 胰岛素敏感性 高危肥胖 Metabolically healthy but obese Insulin sensitivity At-risk obese
  • 相关文献

参考文献34

  • 1Reaven G. The role of insulin resistance in human disease. Di- abetes, 1988, 37: 1595-1607.
  • 2Ruderman LB, Berchtold P, Schneider S. Obesity-associated disorders in normal-weight individuals: Some speculations. Int J Obes, 1982, 6: 151-157.
  • 3Ferrannini E, Natali A, Bell P, et al, On behalf of the Europe- an Group for the Study of Insulin Resistance (EGIR). Insulin resistance and hypersecretion in obesity. J Clin Invest, 1997, 100: 1166-1173.
  • 4Bonora E, Kiechl J, Oberhollenzer F, et al. Prevalence of in- sulin resistance in metabolic disorders: The Bruneck study. Di- abetes, 1998, 47: 1643-1650.
  • 5Brochu M, Tchernof A, Dionne IJ, et al. What are the physi- cal characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal Women? J Clin Endocrinol Metab, 2001, 86: 1020-1025.
  • 6Sims EA. Are there persons who are obese, but metabolically healthy? Metabolism, 2001. 50: 1499-1504.
  • 7Karelis AD, Brochu M, Rabasa-Lhoret R. Can we identify metabolically healthy but obese individuals (MHO)? Diabetes Metab, 2004, 30: 569-572.
  • 8Wildman RP, Muntner P, Reynolds K, et al. The obese with- out cardiometabolic risk factor clustering and the normal weight with cardiometabolie risk factor clustering., prevalence and cor- relates of 2 phenotypes among the US population (NHANES 1999 - 2004). Arch Intern Med, 2008, 168.. 1617-1624.
  • 9Koster A, Stenholm S, Alley DE, et al. Body fat distribution and inflammation among obese older adults with and without metabolic syndrome. Obesity, 2010, 18: 2354-2361.
  • 10Catori G, Lattuada G, Piemonti L, et al. Prevalence, metabol- ic features, and prognosis of metabolically healthy obese Italian individuals, the Cremona Study. Diabetes Care, 2011, 34: 210-215.

同被引文献54

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3060
  • 2中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5230
  • 3Jensen MD,Ryan DH,Apovian CM,et al.2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults,Journal of the American College of Cardiology (2013),doi:10.1016/j.jacc.2013.11.004.
  • 4Waalen J.The genetics of human obesity [J].Transl Res,2014,15(1):336-339.
  • 5Christian B,Tomas A,Stefan S,et al.The fat mass and obesity-associated gene (FTO) is linked to higher plasma levels of the hunger hormone ghrelin and lower serum levels of the satiety hormone leptin in older adults [J].Diabetes,2014,6(2):149-157.
  • 6Takafumi H,Daiji K,Atsuhiko I,et al.Role of free fatty acid receptors in the regulation of energy metabolism[J].Biochim Biophys Acta,2014,13(3):88-92.
  • 7Xin Gao;Shanshan Wang.Advancement of researches on association of non-alcoholic fatty liver disease with type 2 diabetes mellitus[J] Zhonghua Gan Zang Bing Za Zhi,2014,22(3):161-164.
  • 8Jalaja J,Robert D S,Elaine K,et al.Lipid regulation in lipodystrophy versus the obesity-associated metabolic syndrome:the dissociation of HDL-C and Triglycerides[J].Clin Endocrinol Metab,2014:1878.
  • 9Rashi A,Nakhjavani M,Esteghamati A,et al.Association between oxidant/antioxidant markers and proteinuria in type 2 diabetes;results in 142 patients[J].J Adol J Nephrol,2009,22(6):733.
  • 10Naoto K,Hideaki K,Taka-Aki M,et al.Accumulation of oxidative stress-related gene polymorphisms and the risk of coronary heart disease events in patients with type 2 diabetes-An 8-year prospective study.[J] Atherosclerosis,2014,235(2):408-414.

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部